Medicenna Therapeutics Corp. announced that it has received conditional approval from the Toronto Stock Exchange to extend the expiry date of the common share purchase warrants of the Company originally issued on December 21, 2018.
Medicenna Therapeutics Corp. announced that it has received conditional approval from the Toronto Stock Exchange to extend the expiry date of the common share purchase warrants of the Company originally issued on December 21, 2018.